General MedicationsNASALGeneric

OLOPATADINE HYDROCHLORIDE

Standard Dose

0.665MG/SPRAY

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Discontinued

Summary

Approval overview OLOPATADINE HYDROCHLORIDE is listed in Drugs@FDA under application 213757 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient OLOPATADINE HYDROCHLORIDE Form and strength SPRAY, METERED;NASAL - 0.665MG/SPRAY Sponsor HIKMA Submission history Latest submission status date: 2023-04-13 00:00:00.

Structured Monograph

Clinical summary

Approval overview OLOPATADINE HYDROCHLORIDE is listed in Drugs@FDA under application 213757 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient OLOPATADINE HYDROCHLORIDE Form and strength SPRAY, METERED;NASAL - 0.665MG/SPRAY Sponsor HIKMA Submission history Latest submission status date: 2023-04-13 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.